Shanghai Changzheng Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1955-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.shczyy.com
Survey and Reduction of Mortality in Peridialysis Uremic Patients Via Intervention of Risk Factors
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2019-09-13
- Last Posted Date
- 2019-09-20
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 2500
- Registration Number
- NCT04088526
- Locations
- 🇨🇳
Department of Nephrology, Shanghai Changzheng Hospital, Shanghai, Shanghai, China
Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai, China
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2019-06-17
- Last Posted Date
- 2019-06-17
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT03988322
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, China
Anlotinib in Advanced Solid Tumors With FGFR Alteration
- First Posted Date
- 2019-04-29
- Last Posted Date
- 2019-04-29
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03929965
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
Pyrotinib in Combination With Trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar.
- First Posted Date
- 2019-02-18
- Last Posted Date
- 2019-02-18
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03843749
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation.
- First Posted Date
- 2019-01-03
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03792568
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT)
- First Posted Date
- 2018-11-01
- Last Posted Date
- 2021-08-19
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03727763
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
A Multi-center Study：Comparison of ACAF and ACCF in the Treatment of Cervical OPLL
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2018-07-19
- Last Posted Date
- 2018-07-19
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 840
- Registration Number
- NCT03591692
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28
- First Posted Date
- 2017-11-01
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT03329183
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
Comparison of ACAF and ACCF in the Treatment of Cervical OPLL
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2017-10-18
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT03312985
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
Efficacy and Safety of Nerve Root Axial Decompression Surgery in The Treatment of Tethered Cord Syndrome
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2017-08-25
- Last Posted Date
- 2018-09-27
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT03262844
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath